Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas Lund

Showing results (141-150 of 159) with videos related to

Pageof 16
Sort By:
Biorxiv : the Preprint Server for Biology|November 24, 2025
Conkazal-M1 from the MKAVA family of conotoxins - a dual-function protease inhibitor and neuroactive peptideCeleste M Hackney, Thomas Lund Koch, Nicklas Lund Ryding, et al.
Blood Cancer Journal|April 15, 2024
In multiple myeloma, monthly treatment with zoledronic acid beyond two years offers sustained protection against progressive bone diseaseThomas Lund, Michael Tveden Gundesen, Annette Juul Vangsted, et al.
Protein Science : a Publication of the Protein Society|April 22, 2026
Conkazal-M1 from the MKAVA family of conotoxins: A dual-function protease inhibitor and neuroactive peptideCeleste M Hackney, Thomas Lund Koch, Nicklas Lund Ryding, et al.
Ejhaem|April 18, 2024
Nationwide implementation of lenalidomide maintenance in multiple myeloma: A retrospective, real-world studyMads Harsløf, Iman Chanchiri, Trine Silkjær, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|March 27, 2023
Increased Bone Volume by Ixazomib in Multiple Myeloma: 3-Month Results from an Open Label Phase 2 StudyMarta Diaz-delCastillo, Michael Tveden Gundesen, Christian Walther Andersen, et al.
Diagnostics (Basel, Switzerland)|October 23, 2021
[<sup>68</sup>Ga]Ga-NODAGA-E[(cRGDyK)]<sub>2</sub> Angiogenesis PET/MR in a Porcine Model of Chronic Myocardial InfarctionSimon Bentsen, Andreas Clemmensen, Mathias Loft, et al.
Cancers|December 9, 2023
Novel Developments in the Treatment of Multiple Myeloma-Associated Bone DiseaseMartin Johansen, Mette Bøegh Levring, Kasper Stokbro, et al.
Biorxiv : the Preprint Server for Biology|November 19, 2025
From Neuropeptides to Toxins: Illuminating the Origins of Venom Complexity in Cone SnailsThomas Lund Koch, Giada Ferrari, Sunita B Sumanam, et al.
Neuro-Oncology Advances|December 12, 2024
Added prognostic value of DCE blood volume imaging in patients with suspected recurrent or residual glioblastoma-A hybrid [<sup>18</sup>F]FET PET/MRI studyOtto Mølby Henriksen, Aida Muhic, Michael Juncker Lundemann, et al.
American Journal of Hematology|May 27, 2026
Mitigating Teclistamab Toxicity: Prophylactic Tocilizumab and Timing of Immunoglobulin Replacement Therapy in a Nationwide CohortAstrid Hundebøll Torpe, Jonathan Thorsen, Gustav Mathiasen, et al.
Pageof 16

Showing results (141-150 of 159) with videos related to

Sort By:
Pageof 16
Biorxiv : the Preprint Server for Biology|November 24, 2025
Conkazal-M1 from the MKAVA family of conotoxins - a dual-function protease inhibitor and neuroactive peptideCeleste M Hackney, Thomas Lund Koch, Nicklas Lund Ryding, et al.
Blood Cancer Journal|April 15, 2024
In multiple myeloma, monthly treatment with zoledronic acid beyond two years offers sustained protection against progressive bone diseaseThomas Lund, Michael Tveden Gundesen, Annette Juul Vangsted, et al.
Protein Science : a Publication of the Protein Society|April 22, 2026
Conkazal-M1 from the MKAVA family of conotoxins: A dual-function protease inhibitor and neuroactive peptideCeleste M Hackney, Thomas Lund Koch, Nicklas Lund Ryding, et al.
Ejhaem|April 18, 2024
Nationwide implementation of lenalidomide maintenance in multiple myeloma: A retrospective, real-world studyMads Harsløf, Iman Chanchiri, Trine Silkjær, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|March 27, 2023
Increased Bone Volume by Ixazomib in Multiple Myeloma: 3-Month Results from an Open Label Phase 2 StudyMarta Diaz-delCastillo, Michael Tveden Gundesen, Christian Walther Andersen, et al.
Diagnostics (Basel, Switzerland)|October 23, 2021
[<sup>68</sup>Ga]Ga-NODAGA-E[(cRGDyK)]<sub>2</sub> Angiogenesis PET/MR in a Porcine Model of Chronic Myocardial InfarctionSimon Bentsen, Andreas Clemmensen, Mathias Loft, et al.
Cancers|December 9, 2023
Novel Developments in the Treatment of Multiple Myeloma-Associated Bone DiseaseMartin Johansen, Mette Bøegh Levring, Kasper Stokbro, et al.
Biorxiv : the Preprint Server for Biology|November 19, 2025
From Neuropeptides to Toxins: Illuminating the Origins of Venom Complexity in Cone SnailsThomas Lund Koch, Giada Ferrari, Sunita B Sumanam, et al.
Neuro-Oncology Advances|December 12, 2024
Added prognostic value of DCE blood volume imaging in patients with suspected recurrent or residual glioblastoma-A hybrid [<sup>18</sup>F]FET PET/MRI studyOtto Mølby Henriksen, Aida Muhic, Michael Juncker Lundemann, et al.
American Journal of Hematology|May 27, 2026
Mitigating Teclistamab Toxicity: Prophylactic Tocilizumab and Timing of Immunoglobulin Replacement Therapy in a Nationwide CohortAstrid Hundebøll Torpe, Jonathan Thorsen, Gustav Mathiasen, et al.
Pageof 16